Evidence map›Paper›PMID 25792692›Full record

ArticleThe British journal of psychiatry : the journal of mental science2015

Specific effect of the fragile-X mental retardation-1 gene (FMR1) on white matter microstructure.

Tamar Green, Naama Barnea-Goraly, Mira Raman, Scott S Hall, Amy A Lightbody, Jennifer L Bruno, Eve-Marie Quintin, Allan L Reiss

Open access · bronzeAbstract read
In one paragraph

Article in The British journal of psychiatry : the journal of mental science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Developmental studies in fragile X syndrome.Journal of neurodevelopmental disorders · 2020
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Human pluripotent stem cell models of Fragile X syndrome.Molecular and cellular neurosciences · 2016
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Tamar GreenTamar Green, MD, Center for Interdisciplinary Brain Sciences Research, Stanford University School of Medicine, Stanford, California, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv; Naama Barnea-Goraly, MD, Mira Raman, MS, Scott S. Hall, PhD, Amy A. Lightbody, PhD, Jennifer L. Bruno, PhD, Eve-Marie Quintin, PhD, Center for Interdisciplinary Brain Sciences Research, Stanford University School of Medicine, Stanford, California; Allan L. Reiss, MD, Center for Interdisciplinary Brain Sciences Research, Department of Psychiatry and Behavioral Sciences, and Department of Radiology, Stanford University School of Medicine, Stanford, California.
Naama Barnea-GoralyTamar Green, MD, Center for Interdisciplinary Brain Sciences Research, Stanford University School of Medicine, Stanford, California, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv; Naama Barnea-Goraly, MD, Mira Raman, MS, Scott S. Hall, PhD, Amy A. Lightbody, PhD, Jennifer L. Bruno, PhD, Eve-Marie Quintin, PhD, Center for Interdisciplinary Brain Sciences Research, Stanford University School of Medicine, Stanford, California; Allan L. Reiss, MD, Center for Interdisciplinary Brain Sciences Research, Department of Psychiatry and Behavioral Sciences, and Department of Radiology, Stanford University School of Medicine, Stanford, California.
Mira RamanTamar Green, MD, Center for Interdisciplinary Brain Sciences Research, Stanford University School of Medicine, Stanford, California, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv; Naama Barnea-Goraly, MD, Mira Raman, MS, Scott S. Hall, PhD, Amy A. Lightbody, PhD, Jennifer L. Bruno, PhD, Eve-Marie Quintin, PhD, Center for Interdisciplinary Brain Sciences Research, Stanford University School of Medicine, Stanford, California; Allan L. Reiss, MD, Center for Interdisciplinary Brain Sciences Research, Department of Psychiatry and Behavioral Sciences, and Department of Radiology, Stanford University School of Medicine, Stanford, California.
Scott S HallTamar Green, MD, Center for Interdisciplinary Brain Sciences Research, Stanford University School of Medicine, Stanford, California, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv; Naama Barnea-Goraly, MD, Mira Raman, MS, Scott S. Hall, PhD, Amy A. Lightbody, PhD, Jennifer L. Bruno, PhD, Eve-Marie Quintin, PhD, Center for Interdisciplinary Brain Sciences Research, Stanford University School of Medicine, Stanford, California; Allan L. Reiss, MD, Center for Interdisciplinary Brain Sciences Research, Department of Psychiatry and Behavioral Sciences, and Department of Radiology, Stanford University School of Medicine, Stanford, California.
Amy A LightbodyTamar Green, MD, Center for Interdisciplinary Brain Sciences Research, Stanford University School of Medicine, Stanford, California, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv; Naama Barnea-Goraly, MD, Mira Raman, MS, Scott S. Hall, PhD, Amy A. Lightbody, PhD, Jennifer L. Bruno, PhD, Eve-Marie Quintin, PhD, Center for Interdisciplinary Brain Sciences Research, Stanford University School of Medicine, Stanford, California; Allan L. Reiss, MD, Center for Interdisciplinary Brain Sciences Research, Department of Psychiatry and Behavioral Sciences, and Department of Radiology, Stanford University School of Medicine, Stanford, California.
Jennifer L BrunoTamar Green, MD, Center for Interdisciplinary Brain Sciences Research, Stanford University School of Medicine, Stanford, California, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv; Naama Barnea-Goraly, MD, Mira Raman, MS, Scott S. Hall, PhD, Amy A. Lightbody, PhD, Jennifer L. Bruno, PhD, Eve-Marie Quintin, PhD, Center for Interdisciplinary Brain Sciences Research, Stanford University School of Medicine, Stanford, California; Allan L. Reiss, MD, Center for Interdisciplinary Brain Sciences Research, Department of Psychiatry and Behavioral Sciences, and Department of Radiology, Stanford University School of Medicine, Stanford, California.
Eve-Marie QuintinTamar Green, MD, Center for Interdisciplinary Brain Sciences Research, Stanford University School of Medicine, Stanford, California, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv; Naama Barnea-Goraly, MD, Mira Raman, MS, Scott S. Hall, PhD, Amy A. Lightbody, PhD, Jennifer L. Bruno, PhD, Eve-Marie Quintin, PhD, Center for Interdisciplinary Brain Sciences Research, Stanford University School of Medicine, Stanford, California; Allan L. Reiss, MD, Center for Interdisciplinary Brain Sciences Research, Department of Psychiatry and Behavioral Sciences, and Department of Radiology, Stanford University School of Medicine, Stanford, California.
Allan L ReissTamar Green, MD, Center for Interdisciplinary Brain Sciences Research, Stanford University School of Medicine, Stanford, California, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv; Naama Barnea-Goraly, MD, Mira Raman, MS, Scott S. Hall, PhD, Amy A. Lightbody, PhD, Jennifer L. Bruno, PhD, Eve-Marie Quintin, PhD, Center for Interdisciplinary Brain Sciences Research, Stanford University School of Medicine, Stanford, California; Allan L. Reiss, MD, Center for Interdisciplinary Brain Sciences Research, Department of Psychiatry and Behavioral Sciences, and Department of Radiology, Stanford University School of Medicine, Stanford, California areiss1@stanford.edu.
Stanford University · US

Funding

NEUROPSYCHIATRIC-MOLECULAR ASSOCIATIONS IN FRAGILE X SYNR01MH050047 · NIMH · STANFORD UNIVERSITY · PI REISS, ALLAN L · 1993 to 2022
$12.5M
TRAINING FOR CHILD PSYCHIATRY AND CHILD DEVELOPMENTT32MH019908 · NIMH · STANFORD UNIVERSITY · PI IAN H GOTLIB, DAVID S HONG · 1993 to 2026
$6.3M
NIMH NIH HHS MH50047NIMH NIH HHS R01 MH050047NIMH NIH HHS T32 MH019908
6 · The paper itself

Abstract

backgroundFragile-X syndrome (FXS) is a neurodevelopmental disorder associated with intellectual disability and neurobiological abnormalities including white matter microstructural differences. White matter differences have been found relative to neurotypical individuals.

aimsTo examine whether FXS white matter differences are related specifically to FXS or more generally to the presence of intellectual disability.

methodWe used voxel-based and tract-based analytic approaches to compare individuals with FXS (n = 40) with gender- and IQ-matched controls (n = 30).

resultsIndividuals with FXS had increased fractional anisotropy and decreased radial diffusivity values compared with IQ-matched controls in the inferior longitudinal, inferior fronto-occipital and uncinate fasciculi.

conclusionsThe genetic variation associated with FXS affects white matter microstructure independently of overall IQ. White matter differences, found in FXS relative to IQ-matched controls, are distinct from reported differences relative to neurotypical controls. This underscores the need to consider cognitive ability differences when investigating white matter microstructure in neurodevelopmental disorders.

Indexed as

Analysis of VarianceAnisotropyBrain DiseasesCase-Control StudiesDiffusion Tensor ImagingFemaleFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeHumansIntelligenceMalePhenotypeProspective StudiesWhite MatterYoung AdultFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1

Identifiers

PMID25792692
PMCPMC4523928
OpenAlexW2047444498

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.